Spinal anesthesia in a patient on monoclonal antibody treatment: a poisoned chalice? A case report

Reg Anesth Pain Med. 2021 Sep;46(9):828-830. doi: 10.1136/rapm-2021-102557. Epub 2021 Apr 19.

Abstract

Background: Paraplegia is a rare complication of spinal anesthesia.

Case presentation: We report a case of a 68-year-old man who developed postoperative paraplegia and hypoesthesia after spinal anesthesia for an otherwise uncomplicated transurethral resection of the prostate. Acute transverse myelitis was diagnosed based on urgent MRI. A prior history of similar though less severe neurological symptoms after obinutuzumab treatment for follicular lymphoma suggested a potential causative role for obinutuzumab, a novel monoclonal antibody that has not been associated with such devastating neurological side effects yet. High-dose steroid treatment partially attenuated the symptoms, but debilitating hypoesthesia and motor deficit remained present 3 months postoperatively.

Conclusion: The presented case warrants caution when performing neuraxial anesthesia in patients on monoclonal antibody therapies.

Keywords: drug-related side effects and adverse reactions; injections; neurotoxicity syndromes; postoperative complications; spinal.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anesthesia, Spinal* / adverse effects
  • Antibodies, Monoclonal / adverse effects
  • Humans
  • Male
  • Paraplegia
  • Poisons*
  • Transurethral Resection of Prostate*

Substances

  • Antibodies, Monoclonal
  • Poisons